-
Project to Develop Universal Flu Vaccine
An initiative joining academic, private, and national labs is designing a vaccine that covers all influenza strains, with clinical studies expected to begin early next year.
-
Validic Integrating Home Health Data for Clinical Care
An application is being developed for a health care system to integrate data from patients’ home medical devices into their electronic health records and clinical care plans.
-
Phone-Based Lupus Home Test Kit in Development
A home test kit using smartphone imaging is being created by biomedical engineers to detect kidney inflammation caused by lupus, an autoimmune disorder.
-
Blood-Thinning Drugs Linked with Lower Dementia Risk
People with irregular heart rhythms given anti-coagulation drugs to reduce their risk of stroke were also less likely to develop dementia than their counterparts not receiving blood-thinners.
-
Multi-Drug Resistance Antibiotic Developer to Issue IPO
A three year-old company making new antibiotics to treat infections resistant to earlier antibiotics plans to raise some $75 million in its initial public stock offering.
-
Biosimilars Seen Saving U.S. $54 Billion
An analysis of health care costs shows increasing the use of substitute biologic treatments known as biosimilars could save the United States some $54 billion over 10 years.
-
Big Data Analysis Platform for Brainwaves in Development
Two companies in Northern Ireland, U.K. are creating a technology platform applying big data analytics to a collection of brainwaves generated by mobile games for measuring cognitive health.
-
Univ. Lab, Company Broaden Bacterial Vaccine Impact
Researchers from University at Buffalo and a campus spin-off enterprise devised a way to expand the scope of anti-bacterial vaccines, as shown in tests with lab animals.
-
Infographic: World’s Best Employers
In this year’s survey of public companies by Forbes magazine, those from the tech industry are well represented among the best places to work.
-
Company, Foundation Start Multiple Sclerosis Registry
National Multiple Sclerosis Society and the company Corrona LLC are establishing a registry of people with multiple sclerosis in North America to help assess the long-term safety and effectiveness of therapies approved to treat the disorder.